Compare CABO & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABO | SENS |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Industrial Machinery/Components |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 425.5M | 476.9M |
| IPO Year | 2015 | 2014 |
| Metric | CABO | SENS |
|---|---|---|
| Price | $5.57 | $7.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $44.25 | $13.67 |
| AVG Volume (30 Days) | ★ 803.4K | 570.9K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,501,423,000.00 | $16,389,000.00 |
| Revenue This Year | N/A | $82.21 |
| Revenue Next Year | $4.86 | $55.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $5.37 | $4.79 |
| 52 Week High | $167.36 | $10.64 |
| Indicator | CABO | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 26.87 | 31.69 |
| Support Level | N/A | $6.40 |
| Resistance Level | $16.31 | $7.57 |
| Average True Range (ATR) | 2.13 | 0.50 |
| MACD | -0.11 | -0.23 |
| Stochastic Oscillator | 1.92 | 0.15 |
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.